Profen and Elestat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Profen (ibuprofen) and Elestat (epinastine hydrochloride). Common drug interactions include unresponsive to stimuli among females and abscess limb among males.

The phase IV clinical study analyzes what interactions people have when they take Profen and Elestat. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.

What is Elestat?

Elestat has active ingredients of epinastine hydrochloride. eHealthMe is studying from 213 Elestat users. Check the latest studies of Elestat.



On Jul, 28, 2026

13 people who take Profen and Elestat together, and have interactions are studied.

Profen and Elestat drug interactions.

What are the common drug interactions of Profen and Elestat, by gender? *:

female:

  1. Unresponsive to stimuli
  2. Ventricular extrasystoles (premature cardiac contraction)
  3. Viith nerve paralysis
  4. Chronic kidney disease
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Fall
  7. Nausea (feeling of having an urge to vomit)
  8. Vomiting
  9. Abdominal pain upper
  10. Abdominal tenderness

male:

  1. Abscess limb (limb infection)
  2. Cellulitis (infection under the skin)
  3. Anal abscess
  4. Emotional distress
  5. Genital abscess (build up of pus in genital)
  6. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  9. Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)
  10. Gangrene (body tissue dies)

What are the common drug interactions of Profen and Elestat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Abdominal pain upper
  3. Abdominal tenderness
  4. Cholecystitis (infection of gallbladder)
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Dyspepsia (indigestion)
  7. Vomiting

30-39:

n/a

40-49:

  1. Abscess limb (limb infection)
  2. Cellulitis (infection under the skin)
  3. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  4. Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)
  5. Gangrene (body tissue dies)
  6. Groin abscess (pus in groin)
  7. Leukocytosis (increased white blood cells)
  8. Scrotal abscess (pus in scrotum)
  9. Testicular abscess (pus in testes)
  10. Tooth abscess (pus formation in tooth)

50-59:

n/a

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Chronic kidney disease
  3. Renal tubular necrosis (death of kidney tubules)
  4. Acquired macroglossia (large tongue)
  5. Acute respiratory failure
  6. Anticonvulsant drug level above therapeutic
  7. Anxiety
  8. Aortic valve sclerosis (narrowing of the aortic valve)
  9. Arrhythmia (irregular heartbeat)
  10. Atrial hypertrophy (a condition where the left atrium or right atrium of the heart is larger than would be expected)

What are the existing conditions these people have? *

  1. Infection: 5 people, 38.46%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 38.46%
  3. Asthma: 4 people, 30.77%
  4. Constipation: 4 people, 30.77%
  5. Hypersensitivity: 3 people, 23.08%
  6. Back Pain: 2 people, 15.38%
  7. Cough: 2 people, 15.38%
  8. Dry Eyes (lack of adequate tears): 2 people, 15.38%
  9. Eye Infection: 2 people, 15.38%
  10. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Profen and Elestat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Profen and Elestat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Elestat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elestat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen and epinastine hydrochloride (the active ingredients of Profen and Elestat, respectively), and Profen and Elestat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: